FDA just approved a new sickle cell drug—here's what you need to know

Global Blood Therapeutics just secured early approval for its sickle cell drug. CEO Ted Love joins CNBC's Meg Tirell on 'The Exchange' to discuss the new drug and what it could mean for those with the disease.